Test License [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2018-10-07 23:04 (2323 d 21:33 ago) – Posting: # 19414
Views: 4,523

Dear RK,

❝ I applied Test license for some X drug in India, I got permission and I imported the drug (reference) from outside India then conducted one study (pilot). Now I want to conduct one more study (pivotal) with remaining quantity of Reference drug from first study. Here I have some doubts:


❝ 1) Can I use remaining quantity of reference drug for pivotal

No, You can't use the rest of the reference drug for conducting a BE Study with a new ordered reference drug batch, as they are two different Batches (Biobatches).

❝ 2) If we use remaining IPs, Is we need to get Test license permission for pivotal.


Yes, you will need.

Regards,

Osama

Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
23,381 posts in 4,914 threads, 1,663 registered users;
42 visitors (0 registered, 42 guests [including 16 identified bots]).
Forum time: 19:37 CET (Europe/Vienna)

Science is built up with facts, as a house is with stones.
But a collection of facts is no more a science
than a heap of stones is a house.    Henri Poincaré

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5